Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer - Ferris, R L; Geiger, J L; Trivedi, S (Annals of oncology: official journal of the European Society for Medical Oncology, 2016)
. doi:10.1093/annonc/mdw428